UK Analytics Firm GlobalData Said to Attract Takeover Interest
The London-listed company has received approaches from suitors including KKR & Co., the people said, asking not to be identified because the information is private.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
This Self-Driving Car Stock Is Surging on a Major Nvidia Boost
Aeye (LIDR) shares closed sharply higher on Thursday after the lidar system specialist announced a significant collaboration with the AI darling Nvidia (NVDA). According to the company's press release, its flagship Apollo lidar 'has been fully integrated by Nvidia into their DRIVE AGX platform,' which is integral to its autonomous vehicle ecosystem. More News from Barchart NVDA Broken Wing Butterfly Trade Targets A Profit Zone Between 150 and 160 Is Opendoor Stock a Buy at New 52-Week Highs? Can Lucid Motors Stock Hit $7 in 2025? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. At one point today, Aeye stock was seen trading at more than 9x its price set in the first week of April. Significance of Nvidia Collaboration for Aeye Stock The Nvidia collaboration could prove pivotal for LIDR shares as it positions the company as a credible player in a highly competitive lidar market, where differentiation and scalability are key. The team-up brings both technical validation and strategic visibility to Aeye among top-tier OEMs and developers. More importantly, it could unlock substantial commercial opportunities for the Nasdaq-listed firm, especially as NVDA's platform scales across global automakers. Nvidia's mark of confidence also signals Aeye's software-defined architecture is compatible with industry-leading artificial intelligence systems, enhancing its appeal for future deployments. In short, for investors, today's announcement means potential revenue acceleration, improved market positioning, and a stronger narrative around LIDR's long-term viability in autonomous tech – which is why Aeye stock experienced an explosive move to the upside on Thursday. Why LIDR Shares Remain Unattractive to Own Despite the major NVDA boost, investors are recommended approaching Aeye with caution, primarily because it's a penny stock. Penny stocks are widely known for low liquidity and high volatility, which make them susceptible to speculative spikes and potential manipulation. Despite today's surge, Aeye has a small market cap and limited institutional ownership, which can amplify price swings. Therefore, while the Nvidia news is promising, without clear revenue impact or sustained commercial traction, the LIDR share price rally may prove short-lived. Simply put, Aeye stock runs the risk of reversing gains just as quickly once the hype fades. Wall Street Rates Aeye at 'Hold' Only Investors should tread with caution on Aeye shares also because Wall Street analysts warn of a massive decline in them ahead. According to Barchart, the one analyst in coverage has issued a 'Hold' rating only with a target of $1 indicating potential downside of about 65% from current levels. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
China's JD.com Targets $2.6 Billion German Takeover--And Investors Are Paying Attention
(NASDAQ:JD) is deep in talks to acquire German electronics chain Ceconomy AG (MTAGF) in a potential 2.2 billion ($2.6 billion) dealsignaling a calculated push beyond China's borders. The proposed offer stands at 4.60 per share in cash, a 23% premium to Ceconomy's last closing price of 3.75. While the offer isn't binding yet, it marks a renewed attempt by to build a stronger presence in Europe, after walking away from a bid for UK retailer Currys last year. Shares of Ceconomy surged as much as 15.5% on the news. Warning! GuruFocus has detected 2 Warning Sign with JD. The road ahead, though, isn't guaranteed. has been sounding out Ceconomy's biggest shareholdersincluding legacy families like the Kellerhals and Haniel groupsbut some have shown reluctance to lock in firm commitments. Without their support, a formal bid could still stall. The revival of talks, first reported back in February, shows JD's sustained interest in the Frankfurt-listed company, particularly as it looks to counter slowing growth at home through international retail assets with operating scale. Ceconomy runs over 1,000 stores across Europe under the MediaMarkt and Saturn brandsgiving a ready-made retail footprint if the deal closes. Analysts note the tie-up could unlock synergy between JD's logistics infrastructure and Ceconomy's physical presence on the ground. That combination may offer strategic value, especially in last-mile delivery and customer engagement. For now, investors will be watching whether can secure the shareholder backing it needs to take the next step. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
UNH Stock Falls as UnitedHealth Confirms DOJ Probe. How Should You Play Shares Here?
UnitedHealth (UNH) shares inched down on Thursday after the insurance giant confirmed the U.S. Justice Department is investigating its Medicare billing practices. The DOJ is investigating whether the NYSE-listed firm artificially inflated Medicare reimbursements by overstating or exaggerating patient health conditions. More News from Barchart NVDA Broken Wing Butterfly Trade Targets A Profit Zone Between 150 and 160 Is Opendoor Stock a Buy at New 52-Week Highs? Can Lucid Motors Stock Hit $7 in 2025? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Including today's decline, UnitedHealth stock is down more than 50% versus its year-to-date high. Medicare Advantage Matters a Lot for UNH Shares The DOJ's probe adds to a long list of headwinds that have plagued UNH shares this year, including rising medical costs and unexpected management shakeup. An investigation into the Medicare-focused business is significant for investors as it accounted for nearly one-third of the company's overall revenue in 2024. The investigation could result in fines, further damage to the insurer's reputation, or even revised reimbursement policies, potentially leading to added pressure on UnitedHealth stock. If the company is indeed found guilty of fraud in Medicare billing practices, it could shatter investor sentiment and trigger a further decline in its share price in the second half of 2025. Is it Time to Sell UnitedHealth Stock Now? According to Jared Holz, a Mizuho strategist, the DOJ investigation may not be an adequate reason to sell UnitedHealth shares since the possibility of a probe was well-telegraphed and didn't really come as a shock for investors. The investment firm maintains its 'Buy' rating on the world's largest health insurance firm with a $350 price target indicating potential upside of nearly 25% from here. A historically low valuation and the management's expectations that earnings will still grow in fiscal 2026 were cited as reasons for the bullish call on UNH stock in Mizuho's latest research note to clients. What's also worth mentioning is that UnitedHealth insiders have actually been aggressive buyers of the healthcare stock through its ongoing turmoil in 2025. UnitedHealth Remains a Wall Street Favorite While things haven't been pleasant for UnitedHealth stock for quite some time, it still hasn't fallen out of favor with Wall Street analysts. The consensus rating on UNH shares remains at 'Moderate Buy' with the mean target of roughly $357 indicating potential upside of more than 25% from current levels. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
